INTRODUCTION
EB virus (Epstein-Barr virus, EBV) is associated with kinds of human tumors, such as nasopharyngeal cancer and Burrkitt lymphoma [1] [2] . Due to the large genome with 172kb, EBV is not easy for the genetic manipulation during the viral study in the context of the whole genome. The BAC-EBV is abacterial artificial chromosome (BAC)-based plasmid that contains the complete Epstein-Barr virus (EBV) large genome of 172 kb, the E.Coli F factor, selection markers and GFP. [3] the E. Coli F factor as used in the bacterial artificial chromosome (BAC) vector was introduced into the genome of EBV. The F factor ensures the genome replication with a lowcopy number (1 copy) in bacteria strictly. BACbased EBV genome can accurately replicates with the BAC's replication, and is possible for the genetic modification in bacteria using the homologous recombination. In previously studies, recombinant virus particles from BAC-EBV plasmid infected the nasopharyngeal epithelial cells (NPC) in a low level of efficiency, and the strong sensitivity of the NPC to hygromycin(hyg) leads to the difficulty for the the stable selection . Thus, we alter the original hyg gene to neo resistance gene (neo) in the BAC-EBV genome by the homologous recombination under the redαβγ system. And establish the stable transfected 293 cell line. This cell line will easy to get recombinant EB virus particles with the neo resistance, and lays a foundation for the establishment of cell models in the study of EBVassociated NPC (nasopharyngeal carcinoma).
MATERIALS AND METHODS

Cell types and plasmids
293 was preserved and propagated in our laboratory, cultured in DMEM (GIBCO) supplemented with 10 % fetal bovine serum, 5 % CO2 atmosphere at 37℃. Cells were collected during the exponential growth phase. DMEM (Dulbecco's Modified Eagle's medium) purchased from Hgclone company; pKD46,pKD13,pCP20 were the gifts from E. coli ABSTRACT: To obtain recombinant Epstein-Barr virus (EBV) particles with the neomycin resistance from BAC-EBV with hygrymicin (hyg) gene, homologous recombination was employed for altering the original hyg gene to neo resistance gene in the BAC-EBV genome. The kanamycin marker gene (kan) containing the recombinant protein FLP recognition sites (FRTs) was connected to the neo gene in the vector of pGEM-T using conventional cloning techniques. Both ends of the connective are the arms with 20bp of homology sequences responding to the ends next to the hyg gene. PCR and cloning techniques were further performed to extend homology arms to make them reach 89bp. The linear fragment kan-neo with 89bp of arms was then electroporated into the bacteria containing BAC-EBV genome. Under the mediation of the redαβγ system, the hyg gene in BAC-EBV was replaced by neo gene. A series of methods including antibiotic selection, PCR amplification, sequencing and restriction enzyme digestion were used for the identification of the mutated plasmids. The results showed that BAC-EBV/neo, was constructed as expected. Through the transfection of the BAC-EBV/neo plasmid, G418 selection, and GFP observation, we established 293-EBV/neo cell line. This research lays a foundation for the establishment of broader cell models in the study of EBV-associated pathogenic mechanisms. KEY WORDS: Epstein-Barr virus; homologous recombination; BAC; GFP Genetic Stock enter (CGSC), Department of Molecular and Cellular Development Biology, Yale University. BAC-EBV was kindly providely by prof.Dr.W.Hammerschmid [3] [4] .
PCR amplification to the target linear fragments
The kan gene fragment containing FRT sites was connected to the vector pcDNA3.1(+) in previous studies [4] . This fragment upstream includes the homology gene with 20bp and restriction enzyme cutting site, BamHI, locates in the fragment downstream. PCR amplified the neo gene through the designed specific primer. And the neo fragment upstream was introduced into the BamHI site to easy to connect the kan gene fragment. The neo gene fragment downstream also contained 20bp homology next to hyg gene. The connective fragment "-arm1-kan-neo-arm2" (Figure. 
Established of BAC-EBV/neo stable transfected 293 cell line
Accroding to the manufacturer's introductions of the Lipofectamine® Transfection Reagent from Invitrogen Company, plasmid EBV-EBV/neo was transfected into 293 in a 50mm culture flask. After 48 hours, the cells were selected by different levels of G418 (400 mg/ml, 600 mg/ml, 800 mg/ml, 1000 mg/ml). A fluorescence microscope was used to observe the GFP expression.
RESULTS AND DISCUSSION
Genetic Alteration of Selection Resistence on BAC-EBV Plasmids by Homologous Recombination
The target linear fragment (arm1-kan-neo-arm2) was cloned to T vector. EcoRI restriction enzyme digested the T vector, The results, shown in Figure  2 , indicate that the linear fragment was constructed successfully. And the constructed T vector was sequenced to analyze the correctness of the linear fragment. BAC-EBV, contains EBV genome 172kb from the B95-8, screening of molecular markers and GFP expression element. Because of the large EBVgenome, the conventional enzymatic digestion and connection technology can not introduce mutations in the plasmid BAC-EBV. Homologous recombination technology can solve this problem. This study used the method combined with the appropriate clone methods, successfully replace the hyg gene of the plasmid BAC-EBV .The homologous recombination involves two kinds of the important plasmids, respectively pKD46, pKD13 and pCP20. PKD46 can express the redαβγ system to mediate the homologous recombination. Plasmid pCP20 is able to expresse the recombinant protein FLP to specially recognize the FRT sites, so as to cut off the Kan gene, leaving the "Scar" series69bp.Those plasmids are the temperature sensitive type, and have Amp resistance, when cultured at a 42 ℃, will automatically lose.
After the linear fragment electrotransformed, the positive clones were selected through the different resistance, which have the Cam+ and Kan+ resistance. Then pCP20 was transferred into the competent cells of the positive clones. The kan gene was site-specific excised by pcp20 expressive the Flp/FRT system, leaving a FRT "scar" of 69bp showm in Figure 3 
Establishment of the Stably transfected Cell Line
The plasmid BAC-EBV/neo was transfected into 293 cells. Through selection of the different concentrations of G418, such as 400mg/ml, 600mg/ml, 800mg/ml and 1000mg/ml. The 293-p2089/neo cell line was stable established successfully. The result is shown in Figure 5 . More than 95% of the cells expressed the GFP.GFP expression makes the virus readout convenient and intuitive. GFP has been used in various fields, such as observation of the expression of specific genes, tumor angiogenesis, tumor growth, invasion and metastasis, and curative effect in cancer research and so on [5] [6] [7] . Establishment of the cell line stably transfected with plasmid BAC-EBV/neo provides the cell model of the research of the virus pathogenic mechanisms. 
Conclusions
Homologous recombination is applied to the genetic manipulation for a large genome. This study has used the method to construct the plasmid BAC-EBV/neo on based of plasmid BAC-EBV. And then, establish the 293-EBV/neo cell line stably transfected BAC-EBV/neo. It will provide the object of the researches of the viral pathogenic mechanisms.
